Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Aarhus University Hospital
Århus, DinamarcaPublicaciones en colaboración con investigadores/as de Aarhus University Hospital (29)
2023
-
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56
-
Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review
Seminars in Arthritis and Rheumatism, Vol. 58
-
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants
Circulation: Genomic and Precision Medicine, Vol. 16, Núm. 5, pp. 434-441
-
Titin Missense Variants as a Cause of Familial Dilated Cardiomyopathy
Circulation
2022
-
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997
-
Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): Systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD Open, Vol. 8, Núm. 2
-
Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD open, Vol. 8, Núm. 1
-
Natural History of MYH7-Related Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461
-
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy
Circulation. Arrhythmia and electrophysiology, Vol. 15, Núm. 5, pp. e010075
-
Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD open, Vol. 8, Núm. 1
-
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653
2021
-
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073
-
Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement
European Archives of Oto-Rhino-Laryngology, Vol. 278, Núm. 10, pp. 4091-4099
-
Association of Left Ventricular Systolic Dysfunction among Carriers of Truncating Variants in Filamin C with Frequent Ventricular Arrhythmia and End-stage Heart Failure
JAMA Cardiology, Vol. 6, Núm. 8, pp. 891-901
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy
European Journal of Heart Failure, Vol. 23, Núm. 8, pp. 1276-1286
2020
-
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197
-
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
-
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial
Neurological Research and Practice, Vol. 2, Núm. 1